search
Back to results

Blood Lipid Responses to Diet (BoLD)

Primary Purpose

Nutritional and Metabolic Diseases

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Diet
Sponsored by
University of Oxford
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Nutritional and Metabolic Diseases

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Participant is willing and able to give informed consent for participation in the study. Male or Female, aged ≥18 to ≤65 years Body mass index (BMI) ≥19 to ≤35 kg/m2 No medical condition or relevant drug therapy that is known to affect the liver, adipose tissue, or cardiac metabolism. Weight stable for the previous 3 months Exclusion Criteria: Aged <18 or >65 years BMI <19 or >35 kg/m2 A blood haemoglobin <135 mg/dL for men and <120 mg/dL for women Donated (or lost) ≥250 mL of blood in the previous two months On a weight loss diet or decreased their body weight by >5% in the previous 3 months Currently adhering to or have consumed in the previous 3 months a diet with a notably altered macro-nutrient content (e.g. high-fat - low-carbohydrate diet) Have increased their body weight by >5% in the previous 3 months Any metabolic condition or relevant drug therapy Current smoker History of alcoholism or a greater than recommended alcohol intake (>30 g of alcohol daily for men and >20 g of alcohol daily for women) History of albumin allergy. Pregnant or nursing mothers History of severe claustrophobia

Sites / Locations

  • Oxford Centre for Diabetes, Endocrinology and Metabolism, University of OxfordRecruiting
  • Oxford Centre for Diabetes, Endocrinology and MetabolismRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High carbohydrate, low fat diet

High fat, low carbohydrate diet

Arm Description

65% of energy is derived from carbohydrates, 20% from fat, and 15% from protein.

65% of energy is derived from fat, 20% from carbohydrates, and 15% from protein.

Outcomes

Primary Outcome Measures

Change in plasma triglyceride concentrations [mmol/L]
Change in plasma triglyceride concentrations in response to consumption of macronutrient meal will be measured by basic clinical chemistry before and at the end of the dietary intervention.

Secondary Outcome Measures

Change in liver fat content [%]
Liver fat content (intra-hepatic triglyceride) will be measured before and at the end of the dietary intervention by magnetic resonance imaging/spectroscopy
Change in cardiac fat content [%]
Cardiac fat content will be measured before and at the end of the dietary intervention by magnetic resonance imaging/spectroscopy
Change in the contribution of dietary and adipose tissue derived fatty acids to very low density lipoprotein-triglyceride (VLDL-TG) palmitate
Through measuring the incorporation of [13C]palmitate and [2H2]palmitate in isolated plasma VLDL during a mixed-macronutrient feeding test.
Change in hepatic fatty acid synthesis
Measured by incorporation of [2H2] palmitate from 2H2O into VLDL-triglyceride

Full Information

First Posted
January 9, 2023
Last Updated
July 31, 2023
Sponsor
University of Oxford
search

1. Study Identification

Unique Protocol Identification Number
NCT05973539
Brief Title
Blood Lipid Responses to Diet
Acronym
BoLD
Official Title
Investigating Blood Lipid Responses to Dietary Macronutrient Content
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 15, 2023 (Actual)
Primary Completion Date
January 2028 (Anticipated)
Study Completion Date
January 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oxford

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The macronutrient composition of our diet (proportions of carbohydrates, fats and proteins) strongly influences the way our body stores and utilises substrates (e.g., fats and sugars), which in turn influences our risk of developing cardiometabolic diseases (e.g., coronary artery disease or insulin resistance). The optimal dietary composition to lower the risk of cardiometabolic disease is unknown. In a randomized, parallel design, this study will investigate how the overconsumption of carbohydrates and fats affects blood lipid responses and liver metabolism in adults free from metabolic disease.
Detailed Description
Dietary and lifestyle interventions are central to lowering the risk and preventing the development of metabolic disease, including non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease. There is, however, no one fits all dietary approach, and in the context of diets where an individual is not gaining or losing weight (known as eucaloric), the optimal macronutrient composition associated with a reduced risk of metabolic disease and dyslipidemia is highly debated. For instance, eating less of one macronutrient implies eating more of another; a reduction in the intake of dietary carbohydrates is met by an increase in dietary fats. How this affects one's metabolic health in the setting when someone is not gaining or losing body weight is unclear. Therefore, this study aims to provide an understanding of the effect that the quantity of specific dietary macronutrients (e.g., carbohydrates, fats) have on plasma triglyceride concentrations in both the fasting and postprandial state, liver fat content and metabolism, and cardiac fat content and function. Sixty volunteers free from metabolic disease will be recruited into a randomized, parallel-armed dietary intervention study. Participants will consume either a low carbohydrate, high-fat diet or a high carbohydrate, low-fat diet for up to 28 days. Diets will be eucaloric (i.e., designed to meet the individual participant's energy requirements). Comprehensive in vivo metabolic and physiological testing will be performed before and after the experimental diet to document the effects of the overconsumption of specific macronutrients (i.e., fats or carbohydrates) on liver and lipid metabolism.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nutritional and Metabolic Diseases

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High carbohydrate, low fat diet
Arm Type
Experimental
Arm Description
65% of energy is derived from carbohydrates, 20% from fat, and 15% from protein.
Arm Title
High fat, low carbohydrate diet
Arm Type
Experimental
Arm Description
65% of energy is derived from fat, 20% from carbohydrates, and 15% from protein.
Intervention Type
Other
Intervention Name(s)
Diet
Intervention Description
Eucaloric diet enriched in either carbohydrates or fat (both contributing to 65% total energy intake)
Primary Outcome Measure Information:
Title
Change in plasma triglyceride concentrations [mmol/L]
Description
Change in plasma triglyceride concentrations in response to consumption of macronutrient meal will be measured by basic clinical chemistry before and at the end of the dietary intervention.
Time Frame
Pre- and post-diet [21-28 days]
Secondary Outcome Measure Information:
Title
Change in liver fat content [%]
Description
Liver fat content (intra-hepatic triglyceride) will be measured before and at the end of the dietary intervention by magnetic resonance imaging/spectroscopy
Time Frame
Pre- and post-diet [21-28 days]
Title
Change in cardiac fat content [%]
Description
Cardiac fat content will be measured before and at the end of the dietary intervention by magnetic resonance imaging/spectroscopy
Time Frame
Pre- and post-diet [21-28 days]
Title
Change in the contribution of dietary and adipose tissue derived fatty acids to very low density lipoprotein-triglyceride (VLDL-TG) palmitate
Description
Through measuring the incorporation of [13C]palmitate and [2H2]palmitate in isolated plasma VLDL during a mixed-macronutrient feeding test.
Time Frame
Pre- and post-diet [21-28 days]
Title
Change in hepatic fatty acid synthesis
Description
Measured by incorporation of [2H2] palmitate from 2H2O into VLDL-triglyceride
Time Frame
Pre- and post-diet [21-28 days]

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Participant is willing and able to give informed consent for participation in the study. Male or Female, aged ≥18 to ≤65 years Body mass index (BMI) ≥19 to ≤35 kg/m2 No medical condition or relevant drug therapy that is known to affect the liver, adipose tissue, or cardiac metabolism. Weight stable for the previous 3 months Exclusion Criteria: Aged <18 or >65 years BMI <19 or >35 kg/m2 A blood haemoglobin <135 mg/dL for men and <120 mg/dL for women Donated (or lost) ≥250 mL of blood in the previous two months On a weight loss diet or decreased their body weight by >5% in the previous 3 months Currently adhering to or have consumed in the previous 3 months a diet with a notably altered macro-nutrient content (e.g. high-fat - low-carbohydrate diet) Have increased their body weight by >5% in the previous 3 months Any metabolic condition or relevant drug therapy Current smoker History of alcoholism or a greater than recommended alcohol intake (>30 g of alcohol daily for men and >20 g of alcohol daily for women) History of albumin allergy. Pregnant or nursing mothers History of severe claustrophobia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
David J Dearlove
Phone
07739460623
Email
david.dearlove@ocdem.ox.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Leane Hodson
Email
leanne.hodson@ocdem.ox.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leane Hodson
Organizational Affiliation
University of Oxford
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford
City
Oxford
ZIP/Postal Code
OX3 7LE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leanne Hodson, PhD
Phone
01865 857224
Email
leanne.hodson@ocdem.ox.ac.uk
Facility Name
Oxford Centre for Diabetes, Endocrinology and Metabolism
City
Oxford
ZIP/Postal Code
OX3 7LE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leanne Hodson
Phone
01865 857224
Email
leanne.hodson@ocdem.ox.ac.uk
First Name & Middle Initial & Last Name & Degree
Leanne Hodson, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There are no plans to share IPD with other researchers

Learn more about this trial

Blood Lipid Responses to Diet

We'll reach out to this number within 24 hrs